BioCentury
ARTICLE | Clinical News

Japanese cedar tree pollen allergy immunotherapy tablet: Phase II/III started

September 22, 2014 7:00 AM UTC

ALK-Abello said partner Torii began a Japanese Phase II/III trial to evaluate TO-206 in about 1,000 patients with Japanese cedar tree pollen-induced allergic rhinitis. Torii and ALK-Abello are partner...